The Amgen Bioprocessing Center Advisory Board (ABCAB) consists of scientists, engineers, academics, and corporate executives who provide support and advice to KGI’s Amgen Bioprocessing Center.
Mr. Daniel Abramzon
Senior Finance Manager, Genentech, Inc.
Dr. Ashraf Amanullah
VP, Process Development and Manufacturing, a Tyr Pharma
Mr. Vincent Anicetti
SVP, Quality and Compliance, Coherus Biosciences (ABCAB Chair 2016- )
Dr. John Aunins
Founder, Janis Biologics LLC
Francis Bach
Director, Sartorius-Stedim Biotech
Dr. Robert Baffi
EVP, operation, BioMarin Pharmacteutical, Inc. (ABCAB Chair – 2014-2015)
Joaquim Cabral
Professor & Director, Institute of B&B, University of Lisbon Instituto Superior Técnico
Dr. Jon Coffman
Director, Bioprocess Development, Boehringer Ingelheim
Tom Cortopassi
Director, Sartorius Stedim
Dr. Larry A. Couture
SVP & Founding Director, City of Hope
Dr. Dennis M. Fenton
Principal, Fenton & Associates LLC
Tom Fletcher
Scientific Director, Irvine Scientific
Dr. Nuno Fontes
Executive Director, Site Head of Process Science, Boehringer-Ingelheim
Mr. Robert Garrahy
VP, Bioprocess Technogies, Broadley-James Corporation
Ms. Amita Goel
Founder and CEO, Celltheon Corporation
Dr. Sam Guhan
VP, Process Development, Amgen, Inc.
Dr. Robert Kiss
Director, Genentech, Inc.
Dr. Brian Lee
President, CEO and Founder, PBS Biotech
Rick Lit
Former VP, Regulatory Affairs and Safety CMC/Biosimilars/Devices
Dr. Gargi Maheshwari
Executive Director, Merck & Co
Bill Rich
VP, External Supply, Amgen
Mr. Vinit Saxena
President and CEO, Separagen Corporation
Chris Schilling
President and CSO, Genomatica Genomatica
Dr. Abhinav Shukla
VP, Process Development and Manufacturing, KBI Biopharma, Inc.
Dr. Tom Smart
Chairman, Buffer Exchange, TheraBiologics Full Spectrum Genetics, Inc.
Weichang Zhou
VP, China WuXi AppTec Co., Ltd.